Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...

Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic ...

Roche and Zealand Pharma announced last month that their amylin analog petrelintide elicited a 9% placebo-controlled weight ...

In a US societal-perspective lifetime simulation based on SURMOUNT-5 data, tirzepatide was projected to deliver lower total ...

While Lilly’s Foundayo was FDA-approved earlier this month, Novo’s Wegovy pill was greenlighted by the agency in December. ・Lilly’s Foundayo was prescribed 3,707 times in its second week on the market ...

The Trump administration has dropped a plan for insurers to provide cheap weight loss drugs to seniors through a Medicare ...

A delay in a Medicare ⁠pilot ⁠to cover obesity drugs due ⁠to health insurers' hesitation to participate in the program is ...

While outcomes were somewhat attenuated in elderly patients, benefits were consistent across sex and age. These findings ...

In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type ...

Obesity may be a contributing factor in more than 10% of infection-related deaths, a new study reveals. The researchers analyzed medical data from nearly 550,000 adults in Finland and the U.K. over a ...

Intervention uses a smartphone app to promote healthy eating and increased activity ...